Clinical neuroscience, close to the evidence.
Neuro Podcases brings researchers and clinicians into careful conversations about the science behind neurological disease. Its recent episodes move from Rett syndrome and Alzheimer’s genetics to FND, epilepsy, COVID-19 brain injury, ALS/FTD, and meningioma trials.
PRESS PLAY
Neuro Podcases is a clinical neuroscience show focused on the research underneath neurological diagnosis, treatment, and patient care. It is not a general brain-facts program. The show spends its time with researchers and clinicians, moving through the mechanisms and clinical questions that shape current neuroscience. Filippo Dallarmellina and Dr. Michael Kearns present the Research Specials as conversations about how scientific advances may improve care, and the episodes follow that lane closely. Recent subjects include Rett syndrome, Alzheimer’s disease genetics, genetic causes of ALS/FTD, functional neurological disorder, neurodevelopmental disorders, COVID-19 brain injury, surgical trials in meningioma, and epilepsy. The register is technical. That is part of the point. A listener may hear discussion of MECP2-deficient mice, neural precursor cell transplantation, intranasal nerve growth factor, microglial genes, amyloid plaques, repetitive proteins, brain injury biomarkers, seizure recurrence, and clinical trial design. The show does not flatten those terms into easy slogans. Instead, it lets guests explain how a finding was reached, what it might show, and where uncertainty still sits. The clinical side matters just as much as the bench science. Functional neurological disorder is discussed through presentation, diagnosis, emergency care, and patient explanation. Meningioma research is tied to seizures, surgery, recurrence risk, fatigue, quality of life, and long-term disease management. Epilepsy treatment is framed through medication withdrawal, driving, pregnancy-related risk, and individual decision-making. The Alzheimer’s conversation turns genetics into a broader picture of immune involvement rather than a single-cause story. Episodes on Rett syndrome and neurodevelopmental disorders connect molecular and animal-model work to possible therapeutic directions. The show’s strongest identity is this blend of specialist vocabulary and clinical consequence. It assumes curiosity and patience. It rewards listeners who want the machinery of neuroscience research, not just the headline version. Neuro Podcases is best approached as a working room for medical science: measured, evidence-minded, and attentive to how discoveries might eventually reach patients.
Made for: Suits a listener who wants serious neuroscience research with clinical context, especially around neurological disease, biomarkers, trials, and treatment reasoning. It also suits medically curious listeners comfortable with technical vocabulary.
What sets it apart: Neuro Podcases stands apart by keeping laboratory mechanisms, clinical decision-making, and patient-care implications in the same conversation. The show’s recent Research Specials lean into the details rather than sanding them down.
Podcast by Neuro Podcases
A ventilated patient leaves almost no exam; you still have to localise the problem.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear research-led discussion of Rett syndrome, from MECP2-deficient mice to possible therapies.
Rett syndrome anchors this episode, with the discussion moving from MECP2-deficient mice toward therapies that could eventually matter for patients. Dr.
Julie Williams explains Alzheimer's risk through genetics, microglia, and the immune system's complex role in disease.
Alzheimer's risk is framed as a web of biology, not a single inherited switch. Professor Julie Williams of Cardiff University walks through what genetics has revealed about immune-system activity, including microglia and the complement system, while keeping amyloid plaques and…
A clear molecular look at ALS and FTD, from C9orf72 repeats to the balance between RNA and protein toxicity.
NeuroPodCases follows the connection between ALS and FTD in a conversation with Professor Adrian Isaacs, whose group studies the molecular mechanisms behind a motor disorder and a condition framed here as mainly behavioural and language-related.
A grounded look at how Wnt signaling and mouse behavior inform developmental brain disorder research.
NeuroPodCases brings developmental brain disorders into a focused molecular frame, using Professor Michelle Jacob's work on autism spectrum disorders and intellectual disability to trace the canonical Wnt signaling pathway.
Brain science before it becomes a headline.
Research Specials from Neuropodcases has Filippo Dallarmellina and Dr.
Professor Julie Williams says late-onset Alzheimer's disease shows 60-80% heritability in twin studies, while early-onset disease makes up about 5% of cases and is about 90% heritable.
Dr.
NeuroPodCases host Dr.
Prof.
Neuro Podcases examines brain injury in COVID-19 with Professor Ben Michael, Director of the Brain Infection and Inflammation Group at the University of Liverpool.
Neuro Podcases hosts Filippo Dallarmellina and Michael Kearns interview Professor Michael Jenkinson about meningioma management and surgical trials.
An interview with Professor Tony Marson about epilepsy research and its impact on patient care.
A clinical neuroscience podcast episode discussing preclinical research on neurological infectious diseases, focusing on encephalitis causes and research.
NeuroPodCases host interviews neurologist Ethan Meltzer of the University of Texas at Dell Medical School about his book How to Think Like a Neurologist.